• 已选条件：
  • × Abemaciclib
 全选  【符合条件的数据共：12条】

1 Differences in metabolic transport and resistance mechanisms of Abemaciclib, Palbociclib, and Ribociclib [期刊论文]

来源：Frontiers in Pharmacology , 2023

作者:Zhimin Zhu, Qiongni Zhu

关键词:targeted therapy;CDK4/6 inhibitors;...

使用许可:Unknown

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

2 Cost-Effectiveness Analysis of Abemaciclib plus Fulvestrant versus Placebo plus Fulvestrant in Patients with Hormone Receptor-Positive, ERBB2-Negative Breast Cancer [期刊论文]

来源：Breast care , 2022

作者:Xie, Qian, Zheng, Hanrui, Li, Qiu

关键词:Cost-effective analysis;Abemaciclib;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

3 Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial [期刊论文]

来源：Breast Cancer Research , 2021

作者:Hiroji Iwata;Masakazu Toi;Peter A. Kaufman;等

关键词:Abemaciclib;Advanced breast cancer;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

4 The role of CDK4/6 inhibitors in early breast cancer [期刊论文]

来源：Breast , 2021

作者:Antonio Llombart-Cussac;Emilio Alba;Juan de la Haba-Rodríguez;等

关键词:Early breast cancer;Cyclin-dependent kinase 4/6 inhibitors;...

使用许可:Unknown

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

5 Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study [期刊论文]

来源：JTO Clinical and Research Reports , 2021

作者:Yanyun Chen, PhD;Johan Vansteenkiste, MD, PhD;Jean-Louis Pujol, MD, PhD;等

关键词:Abemaciclib;KRAS-mutant;...

使用许可:Unknown

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]    

6 Management of Abemaciclib-Associated Adverse Events in Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Safety Analysis of MONARCH 2 and MONARCH 3 [期刊论文]

来源：The oncologist , 2021

作者:Hope S. Rugo;Jens Huober;José A. García-Sáenz;等

关键词:Abemaciclib;Safety;...

使用许可:CC BY

预览  |  原文链接  |  全文  [ 浏览：0 下载：0  ]